Key facts
- This page summarizes Stephen J. Tulipano's Form 4 filing for Stoke Therapeutics, Inc. (STOK).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 19 Mar 2024, 20:36.
Stephen J. Tulipano - 15 Mar 2024 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)
- Reporting relationship
- CFO
- Issuer ticker
- STOK
- Reported as of
- 15 Mar 2024
- Net transaction value
- -$25,102
- SEC form
- 4
- Accepted by SEC
- 19 Mar 2024, 20:36:00 UTC
- Prior SEC filing
- 05 Dec 2023
- Next SEC filing
- 07 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Stephen Tulipano
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Stephen J. Tulipano filed Form 4 for Stoke Therapeutics, Inc. (STOK) on 19 Mar 2024.
Change
- Previous filing in this sequence was filed on 05 Dec 2023.
- Current net transaction value: -$25,102.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
STOK
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +13,100
- Change %
- +111%
- Price
- $0.000000
- Shares after
- 24,862
- Date
- 15 Mar 2024
- Ownership
- Direct
STOK
transaction
Common Stock
Sale
- Transaction value
- $25,102
- Shares
- -4,116
- Change %
- -17%
- Price
- $6.10
- Shares after
- 20,746
- Date
- 19 Mar 2024
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
STOK
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -13,100
- Change %
- -25%
- Price
- $0.000000
- Shares after
- 39,300
- Date
- 15 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 13,100
- Exercise price
- Footnotes
- F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.94 to $6.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F3
Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
Footnote F4
The award vested or vests as to 1/4th of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the Issuer through each vesting date.